Accepted for Publication: March 3, 2015.
Published Online: May 13, 2015. doi:10.1001/jamadermatol.2015.0718.
Study concept and design: Kalb, Lebwohl, Poulin, Fakharzadeh, Calabro, Chevrier.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Kalb, Poulin, Cohen, Goyal, Fakharzadeh, Langholff.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Langholff, You.
Obtained funding: Calabro, Chevrier.
Administrative, technical, or material support: Goyal, Calabro, Chevrier.
Study supervision: Goyal, Fakharzadeh, Calabro, Chevrier.
Conflict of Interest Disclosures: Dr Kalb reported being a consultant for AbbVie, Amgen, Celgene, Janssen Biotech, Leo Pharma, Pfizer, and Taro Pharmaceuticals; reported serving on the dermatology safety monitoring board for ApoPharma and Eli Lilly; and reported receiving grants for clinical research from AbbVie, Amgen, Janssen Biotech, and Merck. Dr Fiorentino reported serving as a consultant for Johnson & Johnson. Dr Lebwohl reported being an investigator and, before March 2014, a paid consultant for AbGenomics, AbbVie, Amgen, Canfite Biopharma, Celgene, Coronado Biosciences, Dermipsor, Eli Lilly, Forward Pharma, GSK-Stiefel, Janssen Biotech, Leo Pharma, Maruho, Meda, Merck, Novartis, Pfizer, Taro Pharmaceuticals, and UCB Pharma. Dr Toole reported serving as an investigator or consultant for Eli Lilly, Amgen, Pfizer, Celgene, and Leo Pharma. Dr Poulin reported receiving research grants or honoraria from Amgen, AbbVie, Celgene, Eli Lilly, Leo Pharma, Janssen Biotech, Incyte, and Pfizer. Dr Cohen reported being a speaker or serving on an advisory board for AbbVie, Dexcel, Janssen Biotech, Medison, Neopharm, Novartis, Perrigo, Pfizer, and Rafa and reported being an investigator for AbbVie, Janssen Biotech, Medison, and Novartis. Dr Leonardi reported serving as a consultant for AbbVie, Amgen, Dermira, Janssen Biotech, Boehringer-Ingleheim, Eli Lilly, Leo Pharma, Sandoz, UCB Pharma, and Pfizer; reported being an investigator for AbbVie, Amgen, Anacor, Celgene, Coherus, Eli Lilly, Galderma, Janssen Biotech, Merck, Pfizer, Sandoz, Stiefel, Leo Pharma, Novartis, and Tolmar; and reported serving on a speakers bureau for AbbVie. Drs Goyal, Fakharzadeh, Chevrier, and Langholff; Mr Calabro; and Ms You are employees of Janssen pharmaceutical companies of Johnson & Johnson and own stock in Johnson & Johnson. No other disclosures were reported.
Funding/Support: This study was sponsored by Janssen Scientific Affairs, LLC.
Role of the Funder/Sponsor: The sponsor had a role in the design and conduct of the study; collection, management, analysis, and interpretation of data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: Cynthia Arnold, BS, Samantha Simpson, BS, and Kristin Ruley Sharples, PhD (Janssen Scientific Affairs, LLC), provided editorial assistance and writing support for the manuscript. Kezhen L. Tang, PhD (Janssen Research & Development, LLC) provided statistical support. Joel Gelfand, MD, MSCE (Hospital of the University of Pennsylvania, Philadelphia), and the PSOLAR Scientific Advisory Committee provided critical review of the analytical plan for the manuscript. None of these individuals received financial compensation for their services outside their usual salaries.